Autres langues RetinalGenix Technologies Inc.

Actions

RTGN

US76133Y1055

Marché Fermé - OTC Markets Autres places de cotation 18:47:02 22/02/2024			Varia. 5j.	Varia. 1 janv.
3,5 ^USD	+12,90 %		-.--%	+13,27 %

01/04	RetinalGenix Technologies Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI
2023	Technologies RetinalGeniX ? Technologies Inc. passe un contrat avec Medsan, Inc. pour fournir des services de tests diagnostiques à son comité d'examen institutionnel afin de mener une étude visant à personnaliser les évaluations médicales pour les patients recevant un traitement pour la dégénérescence maculaire humide.	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

IN DIRETTA DAI MERCATI: Amplifon, Aena, Generali, Nexi, Stellantis, Terna, Zignago Vetro, Novo Nordisk, Pandora, ING, eBay...	02/05
RetinalGenix Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
RetinalGeniX™ Technologies Inc. Granted a Patent for System And Method For Visualization Of Ocular Anatomy	22/02
RetinalGeniX™ Technologies Inc. Granted a Patent for System And Method For Visualization Of Ocular Anatomy	22/02
RetinalGenix Technologies Inc. announced that it has received $4.65 million in funding	09/02
RetinalGenix Technologies Inc. announced that it expects to receive $4.65 million in funding	23/01
RetinalGeniX™ Technologies Inc. Contracts With MEDsan, Inc. to Provide Diagnostic Testing Services for Its Institutional Review Board to Conduct a Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration	26/12
RetinalGeniX?? Technologies Inc. Contracts with Medsan, Inc. to Provide Diagnostic Testing Services for Its Institutional Review Board to Conduct a Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration	26/12
RetinalGeniX Technologies Inc. Appoints Anatoly Dritschilo, M.D. to the Company’s Medical Advisory Board	21/12
RetinalGeniX Technologies Inc. Appoints Anatoly Dritschilo, M.D. to the Company’s Medical Advisory Board	21/12
RetinalGeniX Technologies Inc. Appoints Anatoly Dritschilo, M.D. to the Medical Advisory Board	21/12
RetinalGeniX Technologies Inc. Appoints Dessy Boneva, MD, FACS to the Board of Directors	04/12
RetinalGeniX Technologies Inc. Appoints Dessy Boneva, MD, FACS to the Board of Directors	04/12
RetinalGeniX Technologies Inc. Appoints Dessislava Boneva to its Board of Directors	04/12
RetinalGeniX Technologies Inc. Announces Hiring of Interim CFO	01/12
RetinalGenix Technologies Inc. Appoints Virender Ahluwalia as Interim Chief Financial Officer	01/12
RetinalGeniX Technologies Inc. Appoints Stephen Tannenbaum to the Company's Business Advisory Board	28/11
RetinalGeniX Technologies Inc. Appoints Stephen Tannenbaum to the Company's Business Advisory Board	28/11
RetinalGenix Technologies Inc. Appoints Stephen Tannenbaum to the Business Advisory Board	28/11
RetinalGenix Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues RetinalGenix Technologies Inc.

Actions

RTGN

US76133Y1055

Autres langues

Filtres